Marsilio, S
Khiabanian, H
Fabbri, G
Vergani, S
Scuoppo, C
Montserrat, E
Shpall, E J
Hadigol, M
Marin, P
Rai, K R
Rabadan, R
Devereux, S
Pasqualucci, L
Chiorazzi, N
Article History
First Online: 5 December 2017
Competing interests
: Dr Steven Devereux: Member of Advisory Board of Janssen, Gilead and Merck Sharp and Dohme and recipient of honoraria and travel expenses from Janssen, Gilead and GlaxoSmithKline. Dr Nicholas Chiorazzi: Consultant fee from Janssen Pharmaceuticals, and honorarium from Nodality, Inc. The remaining authors declare no conflict of interest.